LADENBURG THALMANN FINANCIAL SERVICES INC. - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 70 filers reported holding ACELRX PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.87 and the average weighting 0.0%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$19,000
+171.4%
9,076
+167.3%
0.00%
Q3 2019$7,000
-22.2%
3,3950.0%0.00%
Q2 2019$9,000
-25.0%
3,3950.0%0.00%
Q1 2019$12,000
+9.1%
3,395
-26.1%
0.00%
Q4 2018$11,000
-38.9%
4,5950.0%0.00%
Q3 2018$18,000
+100.0%
4,595
-0.5%
0.00%
Q2 2018$9,0000.0%4,6180.0%0.00%
Q1 2018$9,0000.0%4,6180.0%0.00%
Q4 2017$9,000
-50.0%
4,618
+15.4%
0.00%
Q3 2017$18,000
+63.6%
4,000
-20.0%
0.00%
Q2 2017$11,000
-31.2%
5,0000.0%0.00%
Q1 2017$16,000
+23.1%
5,0000.0%0.00%
Q4 2016$13,000
-31.6%
5,0000.0%0.00%
Q3 2016$19,000
+46.2%
5,0000.0%0.00%
Q2 2016$13,000
-18.8%
5,000
-1.8%
0.00%
Q1 2016$16,000
-20.0%
5,0910.0%0.00%
Q4 2015$20,000
+25.0%
5,0910.0%0.00%
Q3 2015$16,000
-27.3%
5,0910.0%0.00%
Q2 2015$22,000
+10.0%
5,0910.0%0.00%
Q1 2015$20,000
-41.2%
5,0910.0%0.00%
-100.0%
Q4 2014$34,000
+466.7%
5,091
+366.6%
0.00%
Q3 2014$6,000
+500.0%
1,091
+1098.9%
0.00%
Q2 2014$1,000910.00%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Perceptive Advisors 6,574,060$27,874,0001.68%
SENZAR ASSET MANAGEMENT, LLC 798,381$3,385,0000.58%
Cormorant Asset Management, LP 850,000$3,604,0000.48%
Palo Alto Investors LP 2,135,739$9,056,0000.40%
Opus Point Partners Management, LLC 99,959$424,0000.34%
Granahan Investment Management 1,582,237$6,709,0000.19%
Joel Isaacson & Co., LLC 70,660$300,0000.08%
MARINER INVESTMENT GROUP LLC 59,700$253,0000.06%
MYCIO WEALTH PARTNERS, LLC 75,000$318,0000.06%
Cornerstone Capital, Inc. 59,200$251,0000.06%
View complete list of ACELRX PHARMACEUTICALS INC shareholders